Sirtris Pharmaceuticals, Inc. (SIRT)
SIRT, the company that researches anti-aging and resveratrol, was up 7.8% today and is starting to look pretty nice:
Today there was news about their new resveratrol-like pill.
Their latest research shows these experimental drug compounds — which are 1,000 times more potent than resveratrol — helped reverse diabetes symptoms and reduce insulin sensitivity in two different studies in diabetic mice and one in rats.
The discovery may have implications well beyond diabetes drugs, which is itself a $19 billion global market.
“We will make a drug to treat one disease, but it will, as an added bonus, protect you against most of the other diseases of the Western world.”
Now this is a stock that people could get excited about.
